Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie Connarn

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Clinical Pharmacology and Therapeutics|September 25, 2023
A Mechanistic Physiologically-Based Pharmacokinetic Platform Model to Guide Adult and Pediatric Intravenous and Subcutaneous Dosing for Bispecific T Cell EngagersXinwen Zhang, Annie Lumen, Hansen Wong, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 23, 2024
A novel Bayesian generative approach for estimating tumor dynamics from published studiesArya Pourzanjani, Saurabh Modi, Jamie Connarn, et al.
ACS Medicinal Chemistry Letters|December 7, 2013
Analogs of the Allosteric Heat Shock Protein 70 (Hsp70) Inhibitor, MKT-077, as Anti-Cancer AgentsXiaokai Li, Sharan R Srinivasan, Jamie Connarn, et al.
Oncotarget|June 11, 2016
Novel cancer stem cell targets during epithelial to mesenchymal transition in PTEN-deficient trastuzumab-resistant breast cancerLichao Sun, Joseph Burnett, Mari Gasparyan, et al.
Arthritis Research & Therapy|August 18, 2022
CC-99677, a novel, oral, selective covalent MK2 inhibitor, sustainably reduces pro-inflammatory cytokine productionRajula Gaur, Kofi A Mensah, Jason Stricker, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Clinical Pharmacology and Therapeutics|September 25, 2023
A Mechanistic Physiologically-Based Pharmacokinetic Platform Model to Guide Adult and Pediatric Intravenous and Subcutaneous Dosing for Bispecific T Cell EngagersXinwen Zhang, Annie Lumen, Hansen Wong, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 23, 2024
A novel Bayesian generative approach for estimating tumor dynamics from published studiesArya Pourzanjani, Saurabh Modi, Jamie Connarn, et al.
ACS Medicinal Chemistry Letters|December 7, 2013
Analogs of the Allosteric Heat Shock Protein 70 (Hsp70) Inhibitor, MKT-077, as Anti-Cancer AgentsXiaokai Li, Sharan R Srinivasan, Jamie Connarn, et al.
Oncotarget|June 11, 2016
Novel cancer stem cell targets during epithelial to mesenchymal transition in PTEN-deficient trastuzumab-resistant breast cancerLichao Sun, Joseph Burnett, Mari Gasparyan, et al.
Arthritis Research & Therapy|August 18, 2022
CC-99677, a novel, oral, selective covalent MK2 inhibitor, sustainably reduces pro-inflammatory cytokine productionRajula Gaur, Kofi A Mensah, Jason Stricker, et al.
Pageof 1